DECEMBER 1, 2017 Patricia Inacio, PhDBY PATRICIA INACIO, PHD Researchers at the MRC Centre for Regenerative Medicine, University of Edinburg have discovered a mechanism that accelerates reprogramming of cells into any other cell type. The finding may help boost drug discovery and cellular therapies for several diseases, including multiple sclerosis (MS). The study reporting the
When peripheral nerves are severed, Schwann cells at the injury site begin to proliferate and exhibit stem cell-like gene expression patterns. By Diana Kwon | December 1, 2017 The paper M.P. Clements et al., “The wound microenvironment reprograms Schwann cells to invasive mesenchymal-like cells to drive peripheral nerve regeneration,” Neuron, 96:98-114.e7, 2017. To protect and
By JNi.Media – 8 Kislev 5778 – November 26, 2017 Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products based in Haifa, Israel, announced last week that the US Patent and Trademark Office had issued it a patent titled, “Skeletal muscle regeneration using mesenchymal system cells.” Mesenchymal stromal cells are spindle-shaped plastic-adherent cells
Jamie A. Textor, Kaitlin C. Clark, Naomi J. Walker, Fabio A. Aristizobal, Amir Kol, Sarah S. LeJeune, Andrea Bledsoe, Arik Davidyan, Sarah N. Gray, Laurie K. Bohannon-Worsley, Kevin D. Woolard, Dori L. Borjesson Abstract Distal extremity wounds are a significant clinical problem in horses and humans and may benefit from mesenchymal stem cell (MSC) therapy.
Published online 2017 Oct 12. doi: 10.1038/cddis.2017.514 Manuel Scimeca,1,2,10 Antonietta Salustri,3,10 Elena Bonanno,1,10 Daniela Nardozi,1 Cecilia Rao,4 Eleonora Piccirilli,4 Maurizio Feola,4 Virginia Tancredi,5 Annamaria Rinaldi,5 Giovanni Iolascon,6 Augusto Orlandi,3 Elena Gasbarra,4 Nicola Maffulli,7,8 Maria Luisa Brandi,9 and Umberto Tarantino4,* Abstract Pentraxin 3 (PTX3) is a multifunctional glycoprotein regulating inflammatory response, cell proliferation and migration and
New Hope for Heart Attack Patients With Beating Heart Patch BERNADINE RACOMA August 25, 2017 CHICAGO (Ivanhoe Newswire) – Osteoarthritis is the most common form of arthritis in the U.S., affecting nearly 27 million adults. It is currently an incurable disease in which the joints deteriorate. Now, a therapy that has been used in eye
Global Cancer Gene Therapy Market 2017-2022: Expansion in Pharmaceutical Landscape & Growing Demand for Convenience August 24, 2017 “Global Cancer Gene Therapy Market Professional Survey Report 2017-2022” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to
Study Highlights Promise, Questions in Quest for Stem Cell-based MS Treatments AUGUST 24, 2017 Jared Kaltwasser A promising report from India appears to bolster the case that stem cell therapies might one day reverse the progression of multiple sclerosis (MS), but experts say there remain many more questions than answers when it comes to the
Why do hair loss prevention and treatment industries pay attention to P1P, a cell-regenerating substance developed in Korea? PR Newswire Aug. 24, 2017, 09:46 AM ANYANG, South Korea, Aug. 24, 2017 /PRNewswire/ — P1P (Phytosphingosine 1 Phosphate), a cell-regenerating substance developed in Korea, which is thought to be effective in overcoming hair loss caused by
Mayo Clinic, University of Minnesota develop ‘robocop’ stem cells to fight cancer By JEREMY OLSON , STAR TRIBUNE August 19, 2017 – 6:08 PM Researchers at the Mayo Clinic and the University of Minnesota say they’re on the brink of a new era in cancer care — one in which doctors extract a patient’s white
